These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Incidence of Acute Endophthalmitis after Intravitreal Antivascular Endothelial Growth Factor Injection in Age-related Macular Degeneration. Seong HJ; Park YM; Kim J; Son KJ; Chung EJ Korean J Ophthalmol; 2022 Oct; 36(5):435-442. PubMed ID: 35989065 [TBL] [Abstract][Full Text] [Related]
9. Incidence and Outcomes of Infectious and Noninfectious Endophthalmitis after Intravitreal Injections for Age-Related Macular Degeneration. Daien V; Nguyen V; Essex RW; Morlet N; Barthelmes D; Gillies MC; Ophthalmology; 2018 Jan; 125(1):66-74. PubMed ID: 28801117 [TBL] [Abstract][Full Text] [Related]
10. Disease quiescence in endophthalmitis patients treated with anti-VEGF injections for retinal pathologies. Vofo BN; Saada M; Rivera A; Cohen S; Jaouni T; Khateb S BMC Ophthalmol; 2024 Feb; 24(1):73. PubMed ID: 38365648 [TBL] [Abstract][Full Text] [Related]
11. Recent trends in anti-vascular endothelial growth factor intravitreal injections: a large claims database study in Japan. Hashimoto Y; Okada A; Matsui H; Yasunaga H; Aihara M; Obata R Jpn J Ophthalmol; 2023 Jan; 67(1):109-118. PubMed ID: 36508060 [TBL] [Abstract][Full Text] [Related]
12. Association of Acute Endophthalmitis With Intravitreal Injections of Corticosteroids or Anti-Vascular Growth Factor Agents in a Nationwide Study in France. Baudin F; Benzenine E; Mariet AS; Bron AM; Daien V; Korobelnik JF; Quantin C; Creuzot-Garcher C JAMA Ophthalmol; 2018 Dec; 136(12):1352-1358. PubMed ID: 30242325 [TBL] [Abstract][Full Text] [Related]
13. The Influence of Universal Face Mask Use on Endophthalmitis Risk after Intravitreal Anti-Vascular Endothelial Growth Factor Injections. ; Patel SN; Tang PH; Storey PP; Wolfe JD; Fein J; Shah SP; Chen E; Abbey A; Ferrone PJ; Shah CP; Liang MC; Stem MS; Ali Khan M; Yonekawa Y; Garg SJ Ophthalmology; 2021 Nov; 128(11):1620-1626. PubMed ID: 34019955 [TBL] [Abstract][Full Text] [Related]
14. Anti-vascular endothelial growth factor biosimilars for neovascular age-related macular degeneration. Sunaga T; Maeda M; Saulle R; Ng SM; Sato MT; Hasegawa T; Mason AN; Noma H; Ota E Cochrane Database Syst Rev; 2024 Jun; 6(6):CD015804. PubMed ID: 38829176 [TBL] [Abstract][Full Text] [Related]
15. Incidence and clinical features of post-injection endophthalmitis according to diagnosis. Rayess N; Rahimy E; Shah CP; Wolfe JD; Chen E; DeCroos FC; Storey P; Garg SJ; Hsu J Br J Ophthalmol; 2016 Aug; 100(8):1058-61. PubMed ID: 26584579 [TBL] [Abstract][Full Text] [Related]
16. Endophthalmitis following intravitreal injection of anti-VEGF agents: long-term outcomes and the identification of unusual micro-organisms. Sachdeva MM; Moshiri A; Leder HA; Scott AW J Ophthalmic Inflamm Infect; 2016 Dec; 6(1):2. PubMed ID: 26758203 [TBL] [Abstract][Full Text] [Related]
17. Incidence of endophthalmitis and use of antibiotic prophylaxis after intravitreal injections. Cheung CS; Wong AW; Lui A; Kertes PJ; Devenyi RG; Lam WC Ophthalmology; 2012 Aug; 119(8):1609-14. PubMed ID: 22480743 [TBL] [Abstract][Full Text] [Related]